IL-2 in Refractory Autoimmune Encephalitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 12, 2019

Study Completion Date

June 12, 2019

Conditions
Encephalitis
Interventions
DRUG

Proleukin

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02714959 - IL-2 in Refractory Autoimmune Encephalitis | Biotech Hunter | Biotech Hunter